Product image of Pantoprazol Pharmline (Pantoprazole) supplied by GNH India

Pantoprazol Pharmline

Active Ingredient:
Pantoprazole
Origin:
EU

Pantoprazol Pharmline (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Pharmline, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH India supplies Pantoprazol Pharmline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pharmline Company Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazol Pharmline belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion.

  • Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
  • Erosive duodenal ulcer: accelerates ulcer healing and reduces risk of recurrence.
  • Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours.

How It Works

  • Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, inhibiting the final step of acid production. This suppression of gastric acid secretion lowers gastric pH, allowing damaged mucosa to heal and reducing acid‑related symptoms.

Side Effects

Adverse reactions to Pantoprazol Pharmline are generally mild to moderate and vary in frequency.

Common Side Effects

  • Headache: mild, transient headache reported in clinical studies.
  • Diarrhoea: loose stools occurring in a minority of patients.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Clostridioides difficile infection: persistent diarrhoea indicating possible colonic overgrowth.
  • Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
  • Fracture risk: potential decrease in bone mineral density with long‑term use.
  • Liver enzyme elevation: increased ALT/AST indicating hepatic stress.

Precautions & Warnings

When prescribing Pantoprazol Pharmline, clinicians should consider several safety aspects.

  • Assess renal function: dose adjustment may be required in severe impairment.
  • Monitor electrolytes: prolonged therapy can affect magnesium and potassium levels.
  • Evaluate bone health: long‑term use may increase fracture risk, especially in elderly patients.
  • Review concomitant medications: potential for drug‑drug interactions, particularly with antiplatelet agents.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.

Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Avoid Interactions

Pantoprazol Pharmline can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect may increase cardiovascular event risk.
  • Atazanavir: decreased absorption leading to loss of antiviral efficacy.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR, requiring more frequent monitoring.
  • Methotrexate: reduced renal clearance may raise serum levels.
  • Digoxin: slight increase in serum concentration, monitor for toxicity.

Frequently Asked Questions

Pantoprazol Pharmline is a proton pump inhibitor indicated for gastro‑oesophageal reflux disease, erosive duodenal ulcers and Zollinger‑Ellison syndrome, all of which involve excessive stomach acid production that the drug helps to control.

Pantoprazole irreversibly inhibits the gastric H+/K+‑ATPase (proton pump) on parietal cells, blocking the final step of acid secretion. This lowers gastric acidity, allowing damaged tissue to heal and relieving acid‑related symptoms.

The prescribed dose of Pantoprazol Pharmline is determined by the treating physician based on the specific indication, severity of disease and patient characteristics. Dosage regimens are not disclosed here.

Pantoprazole is classified as pregnancy category B in the EU, indicating no evidence of risk in animal studies but limited human data. It should be used during pregnancy or lactation only if clearly needed after a careful risk‑benefit assessment by the prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Pantoprazole belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, it has a similar efficacy profile but a lower potential for drug‑drug interactions with clopidogrel.

Store Pantoprazol Pharmline tablets at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Do not store in a humid environment or expose to excessive heat.

Pantoprazol Pharmline is supplied as oral tablets that should be swallowed whole with water, preferably before a meal. The tablet should not be crushed, chewed or split unless specifically instructed by a healthcare professional.

Serious adverse events include severe allergic reactions, Clostridioides difficile‑associated diarrhoea, hypomagnesemia, and an increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhoea, muscle cramps or unexplained fractures.

Patients with known hypersensitivity to pantoprazole or other proton pump inhibitors should not use this product. Caution is also advised for individuals with severe liver impairment, those on clopidogrel therapy, and pregnant or breastfeeding women unless the benefit outweighs the risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT